Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 6,598,982 $ 8,901,875
Prepaid Expenses 855,257 58,078
Total Current Assets 7,454,239 8,959,953
Property And Equipment, Net 0 0
Other Assets    
Operating Lease - Right Of Use Asset 201,832 27,225
Security Deposit 32,058 3,000
Total Other Assets 233,890 30,225
Total Assets 7,688,129 8,990,178
Current Liabilities:    
Accounts Payable 520,367 654,333
Current Portion Of Long-term Operating Lease 67,029 15,178
Convertible Debentures Payable 240,000 240,000
Deferred R&d Obligations - Participation Agreements 1,003,702 1,106,320
Deferred R&d Obligations - Participation Agreements Related Parties 334,807 369,037
Accrued Interest 96,478 95,886
Accrued Liabilities - Payroll And Directors Fees 138,334 467,215
Note Payable 558,756 0
Total Current Liabilities 2,959,473 2,947,969
Long-term Liabilities:    
Long-term Operating Lease, Net Of Current Position 144,138 0
Total Long-term Liabilities 144,138 0
Total Liabilities 3,103,611 2,947,969
Stockholders' Equity:    
Common Stock, $0.001 Par Value, 150,000,000 Shares Authorized; 9,419,660 And 9,419,660 Issued And Outstanding At March 31, 2022 And December 31, 2021 9,420 9,420
Additional Paid-in Capital 114,830,459 114,259,830
Accumulated Deficit (110,255,361) (108,227,041)
Total Stockholders' Equity 4,584,518 6,042,209
Total Liabilities And Stockholders' Equity $ 7,688,129 $ 8,990,178